Metagenomi Therapeutics, Inc.
MGXBiotechnology
$0.78−6.01%As of Oct 30vs prior close
- Market cap
- $29.5M
- P/E (TTM)
- –
- From 52W high
- −69.28%
- EPS (LTM)
- -$2.29
- Revenue (LTM)
- $22.3M
- Net margin
- -384.61%
- Dividend yield
- 0.00%
Nomior Score
9
Steady ProfileBottom 2% of the scored universe
Growth51
Quality33
Value13
Momentum1
Resilience36
Growth
−24.95%revenue a year over 2 fiscal years
YE23 $44.8MLTM $22.3M
Connections
Revenue to profitQ1 YE26
The operating loss was 1970% of revenue, wider by 1296 pts on a year.
Who owns it
1fund